Handelsinvest Investeringsforvaltning Regeneron Pharmaceuticals, Inc. Transaction History

Handelsinvest Investeringsforvaltning

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$700.03 - $830.35 $942,240 - $1.12 Million	-1,346 Reduced 42.06%	1,854 $1.33 Million
Q1 2023 Apr 27, 2023	SELL	$680.49 - $826.97 $725,402 - $881,550	-1,066 Reduced 24.99%	3,200 $2.63 Million
Q4 2022 Jan 18, 2023	SELL	$705.89 - $766.39 $1.65 Million - $1.79 Million	-2,333 Reduced 35.35%	4,266 $3.08 Million
Q3 2022 Nov 07, 2022	BUY	$573.97 - $724.32 $573,970 - $724,320	1,000 Added 17.86%	6,599 $4.55 Million
Q2 2022 Jul 13, 2022	SELL	$548.35 - $738.84 $932,743 - $1.26 Million	-1,701 Reduced 23.3%	5,599 $3.31 Million
Q1 2022 Apr 26, 2022	BUY	$595.12 - $698.43 $178,536 - $209,528	300 Added 4.29%	7,300 $5.1 Million
Q4 2021 Feb 07, 2022	BUY	$543.48 - $670.97 $1.63 Million - $2.01 Million	3,000 Added 75.0%	7,000 $4.42 Million
Q3 2021 Nov 02, 2021	BUY	$574.03 - $680.96 $2.3 Million - $2.72 Million	4,000 New	4,000 $2.42 Million

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Handelsinvest Investeringsforvaltning, based on Form 13F filings with the SEC.

Stay updated on Handelsinvest Investeringsforvaltning with notifications on news.